| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 47 | 2012 | 892 | 3.680 |
Why?
|
| Motor Activity | 41 | 2012 | 621 | 1.730 |
Why?
|
| Dopamine | 20 | 2010 | 474 | 1.610 |
Why?
|
| Mice, Inbred C57BL | 85 | 2012 | 2790 | 1.600 |
Why?
|
| Reward | 13 | 2005 | 201 | 1.590 |
Why?
|
| Conditioning, Operant | 21 | 2012 | 241 | 1.520 |
Why?
|
| Cocaine | 17 | 2006 | 555 | 1.490 |
Why?
|
| Prenatal Exposure Delayed Effects | 17 | 2010 | 154 | 1.470 |
Why?
|
| Mice | 106 | 2013 | 8472 | 1.260 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 11 | 2013 | 52 | 1.170 |
Why?
|
| Behavior, Animal | 25 | 2012 | 470 | 1.130 |
Why?
|
| Animals | 116 | 2013 | 20877 | 0.950 |
Why?
|
| Aging | 11 | 2013 | 911 | 0.910 |
Why?
|
| Dose-Response Relationship, Drug | 33 | 2012 | 1745 | 0.870 |
Why?
|
| Discrimination Learning | 9 | 2004 | 45 | 0.840 |
Why?
|
| Central Nervous System Depressants | 9 | 2008 | 182 | 0.820 |
Why?
|
| Corpus Striatum | 8 | 2010 | 278 | 0.750 |
Why?
|
| Naltrexone | 5 | 2003 | 195 | 0.740 |
Why?
|
| Methylphenidate | 6 | 2012 | 97 | 0.650 |
Why?
|
| Sex Characteristics | 10 | 2007 | 295 | 0.640 |
Why?
|
| Substantia Nigra | 7 | 2010 | 102 | 0.610 |
Why?
|
| Cocaine-Related Disorders | 5 | 2007 | 504 | 0.610 |
Why?
|
| Disease Models, Animal | 14 | 2013 | 2550 | 0.590 |
Why?
|
| Brain | 21 | 2008 | 2175 | 0.580 |
Why?
|
| Body Weight | 17 | 2010 | 554 | 0.560 |
Why?
|
| Parkinsonian Disorders | 3 | 2013 | 43 | 0.540 |
Why?
|
| Reinforcement Schedule | 8 | 2007 | 59 | 0.500 |
Why?
|
| AIDS Dementia Complex | 6 | 2007 | 20 | 0.490 |
Why?
|
| Dopamine Antagonists | 2 | 2004 | 65 | 0.490 |
Why?
|
| Narcotic Antagonists | 3 | 2000 | 184 | 0.490 |
Why?
|
| Self Administration | 12 | 2012 | 419 | 0.480 |
Why?
|
| Male | 72 | 2012 | 37281 | 0.450 |
Why?
|
| Pregnancy | 30 | 2010 | 2331 | 0.440 |
Why?
|
| 4-Aminobutyrate Transaminase | 1 | 2012 | 4 | 0.430 |
Why?
|
| Vigabatrin | 1 | 2012 | 8 | 0.430 |
Why?
|
| Phencyclidine | 6 | 1989 | 17 | 0.430 |
Why?
|
| Phenobarbital | 9 | 1986 | 25 | 0.420 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 2 | 2008 | 7 | 0.420 |
Why?
|
| Alcohol Drinking | 7 | 2010 | 805 | 0.410 |
Why?
|
| Receptors, Dopamine D1 | 4 | 2008 | 87 | 0.390 |
Why?
|
| Neurons | 7 | 2010 | 881 | 0.380 |
Why?
|
| Alcoholism | 5 | 2007 | 1109 | 0.370 |
Why?
|
| Brain Chemistry | 13 | 2006 | 173 | 0.370 |
Why?
|
| Narcotics | 4 | 1997 | 65 | 0.370 |
Why?
|
| Food Deprivation | 6 | 2000 | 22 | 0.360 |
Why?
|
| Quinuclidinyl Benzilate | 5 | 1989 | 10 | 0.350 |
Why?
|
| Quinuclidines | 5 | 1989 | 10 | 0.340 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 659 | 0.340 |
Why?
|
| Tyrosine 3-Monooxygenase | 7 | 2010 | 71 | 0.330 |
Why?
|
| Cues | 4 | 2011 | 654 | 0.330 |
Why?
|
| Neostriatum | 3 | 2010 | 60 | 0.330 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 3 | 1995 | 27 | 0.320 |
Why?
|
| Extracellular Fluid | 2 | 2006 | 29 | 0.310 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2007 | 30 | 0.300 |
Why?
|
| Fructose | 1 | 2007 | 51 | 0.290 |
Why?
|
| Conditioning, Classical | 3 | 2006 | 57 | 0.290 |
Why?
|
| Female | 51 | 2010 | 38015 | 0.280 |
Why?
|
| Central Nervous System Stimulants | 4 | 2011 | 221 | 0.270 |
Why?
|
| Hybridization, Genetic | 1 | 2005 | 9 | 0.270 |
Why?
|
| Nipecotic Acids | 1 | 2005 | 11 | 0.270 |
Why?
|
| Gene Dosage | 1 | 2005 | 47 | 0.270 |
Why?
|
| Heroin | 1 | 2005 | 49 | 0.250 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 4 | 2010 | 82 | 0.250 |
Why?
|
| Receptors, Serotonin | 2 | 2005 | 74 | 0.240 |
Why?
|
| Mice, Knockout | 11 | 2010 | 1692 | 0.240 |
Why?
|
| Dopamine Agents | 3 | 2008 | 56 | 0.240 |
Why?
|
| Cognition Disorders | 4 | 2007 | 342 | 0.240 |
Why?
|
| Xenobiotics | 1 | 2003 | 17 | 0.240 |
Why?
|
| Behavior, Addictive | 2 | 2006 | 317 | 0.230 |
Why?
|
| Toxicity Tests | 1 | 2003 | 26 | 0.230 |
Why?
|
| Reproduction | 1 | 2003 | 48 | 0.230 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2006 | 152 | 0.220 |
Why?
|
| Pregnancy, Animal | 2 | 1995 | 27 | 0.220 |
Why?
|
| Amphetamine | 2 | 1995 | 77 | 0.210 |
Why?
|
| Psychomotor Performance | 2 | 1996 | 213 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 2 | 2013 | 102 | 0.200 |
Why?
|
| Fetus | 3 | 1996 | 157 | 0.190 |
Why?
|
| Methadone | 4 | 1983 | 32 | 0.190 |
Why?
|
| Catheters, Indwelling | 2 | 1998 | 72 | 0.190 |
Why?
|
| Litter Size | 4 | 1995 | 14 | 0.180 |
Why?
|
| Serotonin Antagonists | 1 | 2000 | 31 | 0.180 |
Why?
|
| Nucleus Accumbens | 7 | 2008 | 417 | 0.180 |
Why?
|
| Eating | 4 | 2007 | 119 | 0.180 |
Why?
|
| Receptors, Opioid, delta | 1 | 2000 | 37 | 0.180 |
Why?
|
| Research Design | 1 | 2003 | 729 | 0.170 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 1998 | 6 | 0.160 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2010 | 109 | 0.160 |
Why?
|
| Stereotaxic Techniques | 1 | 1998 | 35 | 0.160 |
Why?
|
| Alcohol-Related Disorders | 1 | 1999 | 95 | 0.160 |
Why?
|
| Time Factors | 18 | 2006 | 4655 | 0.160 |
Why?
|
| Species Specificity | 5 | 2006 | 302 | 0.160 |
Why?
|
| Dental Materials | 1 | 1998 | 35 | 0.160 |
Why?
|
| Composite Resins | 1 | 1998 | 60 | 0.160 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 3 | 2007 | 21 | 0.160 |
Why?
|
| Models, Biological | 2 | 2013 | 981 | 0.150 |
Why?
|
| Energy Intake | 2 | 1995 | 123 | 0.150 |
Why?
|
| Anesthetics, Local | 1 | 1998 | 83 | 0.150 |
Why?
|
| Cognition | 3 | 2007 | 512 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 2005 | 597 | 0.150 |
Why?
|
| Mice, SCID | 5 | 2007 | 238 | 0.150 |
Why?
|
| Drug Synergism | 4 | 2012 | 260 | 0.150 |
Why?
|
| Eosinophilia-Myalgia Syndrome | 1 | 1996 | 24 | 0.150 |
Why?
|
| Norepinephrine | 7 | 2007 | 276 | 0.150 |
Why?
|
| Dextroamphetamine | 4 | 2006 | 30 | 0.140 |
Why?
|
| Catheterization, Central Venous | 1 | 1997 | 89 | 0.140 |
Why?
|
| Sucrose | 3 | 2005 | 58 | 0.140 |
Why?
|
| Tryptophan | 1 | 1996 | 65 | 0.140 |
Why?
|
| Methamphetamine | 2 | 2008 | 132 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2007 | 59 | 0.140 |
Why?
|
| Fetal Viability | 1 | 1995 | 1 | 0.140 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2007 | 73 | 0.140 |
Why?
|
| Nicotine | 1 | 1999 | 350 | 0.130 |
Why?
|
| Drug Tolerance | 2 | 2007 | 80 | 0.130 |
Why?
|
| Gestational Age | 3 | 1992 | 389 | 0.130 |
Why?
|
| Microdialysis | 4 | 2010 | 147 | 0.130 |
Why?
|
| Injections, Subcutaneous | 4 | 2007 | 87 | 0.130 |
Why?
|
| Azides | 2 | 1992 | 56 | 0.130 |
Why?
|
| Heterozygote | 3 | 2010 | 174 | 0.120 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2006 | 75 | 0.120 |
Why?
|
| Mice, Inbred Strains | 4 | 2007 | 181 | 0.120 |
Why?
|
| Generalization, Stimulus | 2 | 1998 | 5 | 0.120 |
Why?
|
| Radioligand Assay | 3 | 2005 | 109 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 5 | 1996 | 57 | 0.120 |
Why?
|
| Benzodiazepines | 2 | 1992 | 130 | 0.120 |
Why?
|
| Avoidance Learning | 5 | 2005 | 58 | 0.120 |
Why?
|
| Dopamine Agonists | 2 | 2008 | 68 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2010 | 381 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 5 | 2006 | 89 | 0.110 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 3 | 1996 | 40 | 0.100 |
Why?
|
| HIV Infections | 1 | 1999 | 775 | 0.100 |
Why?
|
| Walking | 1 | 2013 | 240 | 0.100 |
Why?
|
| Age Factors | 6 | 2010 | 1860 | 0.100 |
Why?
|
| Mice, Inbred DBA | 3 | 1987 | 120 | 0.100 |
Why?
|
| Catecholamines | 2 | 1989 | 73 | 0.100 |
Why?
|
| Teratogens | 1 | 1990 | 11 | 0.090 |
Why?
|
| Dopaminergic Neurons | 1 | 2010 | 46 | 0.090 |
Why?
|
| Phenytoin | 1 | 1990 | 27 | 0.090 |
Why?
|
| Reaction Time | 2 | 2004 | 170 | 0.090 |
Why?
|
| Water Deprivation | 2 | 2000 | 3 | 0.090 |
Why?
|
| Catheterization | 2 | 2003 | 209 | 0.090 |
Why?
|
| Habituation, Psychophysiologic | 2 | 1999 | 22 | 0.090 |
Why?
|
| Neural Pathways | 3 | 2008 | 323 | 0.090 |
Why?
|
| Urogenital System | 1 | 1989 | 6 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2004 | 134 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 124 | 0.090 |
Why?
|
| Sex Factors | 4 | 2006 | 1265 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 142 | 0.080 |
Why?
|
| Food | 2 | 1999 | 52 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2008 | 447 | 0.080 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2008 | 22 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 128 | 0.080 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 34 | 0.080 |
Why?
|
| Stereoisomerism | 2 | 2007 | 169 | 0.080 |
Why?
|
| Minocycline | 1 | 2008 | 61 | 0.080 |
Why?
|
| Gene Expression | 3 | 2006 | 770 | 0.080 |
Why?
|
| Receptors, Muscarinic | 1 | 1988 | 44 | 0.080 |
Why?
|
| Symporters | 2 | 2005 | 27 | 0.080 |
Why?
|
| Microcomputers | 1 | 1988 | 32 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 134 | 0.080 |
Why?
|
| Phenylisopropyladenosine | 1 | 1987 | 6 | 0.080 |
Why?
|
| Recurrence | 3 | 2008 | 948 | 0.080 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 567 | 0.080 |
Why?
|
| Analysis of Variance | 5 | 2008 | 1039 | 0.080 |
Why?
|
| Caffeine | 1 | 1987 | 81 | 0.080 |
Why?
|
| Estrous Cycle | 1 | 2007 | 23 | 0.080 |
Why?
|
| Individuality | 1 | 2007 | 44 | 0.080 |
Why?
|
| Environment | 2 | 2005 | 115 | 0.070 |
Why?
|
| Adenosine | 1 | 1987 | 165 | 0.070 |
Why?
|
| Ketamine | 1 | 1988 | 57 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 1997 | 334 | 0.070 |
Why?
|
| Temperance | 1 | 2006 | 41 | 0.070 |
Why?
|
| Receptors, AMPA | 1 | 2007 | 99 | 0.070 |
Why?
|
| Chromones | 1 | 2006 | 33 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2007 | 180 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2007 | 411 | 0.070 |
Why?
|
| Algorithms | 2 | 2013 | 1194 | 0.070 |
Why?
|
| Maze Learning | 3 | 2007 | 138 | 0.070 |
Why?
|
| Weight Gain | 2 | 1999 | 135 | 0.070 |
Why?
|
| Alcohol Deterrents | 1 | 2006 | 86 | 0.070 |
Why?
|
| Cell Count | 4 | 2008 | 248 | 0.070 |
Why?
|
| Genetics, Behavioral | 1 | 2005 | 2 | 0.070 |
Why?
|
| Locomotion | 3 | 2004 | 135 | 0.070 |
Why?
|
| Receptors, Dopamine | 2 | 2005 | 119 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 1032 | 0.070 |
Why?
|
| Zidovudine | 1 | 2005 | 27 | 0.070 |
Why?
|
| Linear Models | 1 | 2007 | 521 | 0.070 |
Why?
|
| Esterification | 1 | 2005 | 25 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 120 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2008 | 272 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 236 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2007 | 223 | 0.070 |
Why?
|
| Neuronal Plasticity | 2 | 2005 | 274 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 81 | 0.060 |
Why?
|
| Body Temperature | 4 | 2008 | 116 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 189 | 0.060 |
Why?
|
| Drinking | 2 | 2006 | 35 | 0.060 |
Why?
|
| Pyridines | 1 | 2006 | 261 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 420 | 0.060 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2003 | 41 | 0.060 |
Why?
|
| Drug Interactions | 4 | 2012 | 289 | 0.060 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 135 | 0.060 |
Why?
|
| Cerebral Cortex | 3 | 1998 | 415 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2006 | 435 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 1996 | 74 | 0.060 |
Why?
|
| Animals, Newborn | 3 | 2007 | 396 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 290 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2003 | 106 | 0.060 |
Why?
|
| Maternal Exposure | 1 | 2003 | 75 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2008 | 282 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 2003 | 75 | 0.050 |
Why?
|
| Locus Coeruleus | 1 | 2003 | 55 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.050 |
Why?
|
| Biogenic Amines | 2 | 1985 | 15 | 0.050 |
Why?
|
| Microglia | 3 | 2008 | 143 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 1027 | 0.050 |
Why?
|
| Naloxone | 2 | 1979 | 56 | 0.050 |
Why?
|
| Data Collection | 1 | 2003 | 420 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 1174 | 0.050 |
Why?
|
| Humans | 13 | 2009 | 68525 | 0.050 |
Why?
|
| Swimming | 2 | 2004 | 38 | 0.050 |
Why?
|
| Synaptosomes | 3 | 2010 | 57 | 0.050 |
Why?
|
| Cell Line | 1 | 2005 | 1752 | 0.050 |
Why?
|
| Saccharin | 1 | 2000 | 4 | 0.050 |
Why?
|
| Homer Scaffolding Proteins | 3 | 2005 | 24 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 1981 | 102 | 0.050 |
Why?
|
| Solutions | 1 | 2000 | 115 | 0.050 |
Why?
|
| Tropanes | 1 | 2000 | 3 | 0.050 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2000 | 6 | 0.050 |
Why?
|
| Corticosterone | 2 | 1979 | 51 | 0.050 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 2 | 1997 | 15 | 0.040 |
Why?
|
| Thirst | 1 | 1999 | 4 | 0.040 |
Why?
|
| Generalization, Response | 1 | 1999 | 1 | 0.040 |
Why?
|
| Diet | 3 | 1994 | 513 | 0.040 |
Why?
|
| Methyltyrosines | 2 | 1994 | 6 | 0.040 |
Why?
|
| alpha-Methyltyrosine | 2 | 1994 | 6 | 0.040 |
Why?
|
| Benzazepines | 2 | 1997 | 104 | 0.040 |
Why?
|
| Mazindol | 1 | 1998 | 2 | 0.040 |
Why?
|
| Procaine | 1 | 1998 | 9 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 134 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 1999 | 218 | 0.040 |
Why?
|
| Sindbis Virus | 1 | 1997 | 2 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 88 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 507 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1996 | 12 | 0.040 |
Why?
|
| Immunity | 1 | 1997 | 67 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2003 | 2004 | 0.040 |
Why?
|
| S-Adenosylmethionine | 1 | 1976 | 9 | 0.040 |
Why?
|
| Escape Reaction | 1 | 1976 | 10 | 0.040 |
Why?
|
| Folic Acid Deficiency | 1 | 1976 | 16 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 173 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1996 | 48 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 1997 | 311 | 0.040 |
Why?
|
| Fetal Blood | 1 | 1996 | 131 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 626 | 0.030 |
Why?
|
| Membranes | 1 | 1996 | 26 | 0.030 |
Why?
|
| Weaning | 1 | 1995 | 12 | 0.030 |
Why?
|
| Folic Acid | 1 | 1976 | 121 | 0.030 |
Why?
|
| Equipment Design | 1 | 1997 | 500 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 2 | 2010 | 48 | 0.030 |
Why?
|
| Gliosis | 2 | 2006 | 51 | 0.030 |
Why?
|
| Rats | 5 | 1997 | 5300 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 595 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2007 | 7028 | 0.030 |
Why?
|
| Fatigue | 2 | 2006 | 132 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1753 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 1994 | 56 | 0.030 |
Why?
|
| Genotype | 2 | 2006 | 785 | 0.030 |
Why?
|
| Actigraphy | 1 | 2013 | 28 | 0.030 |
Why?
|
| Macrophages | 3 | 2007 | 647 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 455 | 0.030 |
Why?
|
| Organ Size | 3 | 1996 | 242 | 0.030 |
Why?
|
| Head | 1 | 2013 | 59 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1992 | 5 | 0.030 |
Why?
|
| Urine | 1 | 1992 | 47 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2007 | 1663 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 368 | 0.030 |
Why?
|
| Odorants | 1 | 1992 | 52 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 2006 | 332 | 0.030 |
Why?
|
| Cerebellum | 2 | 2003 | 103 | 0.030 |
Why?
|
| Hippocampus | 2 | 2003 | 471 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 1991 | 56 | 0.030 |
Why?
|
| Reference Values | 1 | 1992 | 579 | 0.030 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Atropine | 2 | 1989 | 29 | 0.020 |
Why?
|
| Auditory Cortex | 1 | 1971 | 43 | 0.020 |
Why?
|
| Synaptic Vesicles | 1 | 2010 | 18 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1971 | 67 | 0.020 |
Why?
|
| Astrocytes | 2 | 2006 | 270 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 1991 | 89 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 121 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 168 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1990 | 34 | 0.020 |
Why?
|
| Postural Balance | 1 | 2010 | 93 | 0.020 |
Why?
|
| Syndrome | 1 | 1990 | 255 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1989 | 50 | 0.020 |
Why?
|
| Ascorbic Acid | 2 | 1979 | 45 | 0.020 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1989 | 13 | 0.020 |
Why?
|
| Hydronephrosis | 1 | 1989 | 12 | 0.020 |
Why?
|
| Ureteral Obstruction | 1 | 1989 | 25 | 0.020 |
Why?
|
| Photomicrography | 1 | 2008 | 14 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2008 | 41 | 0.020 |
Why?
|
| Encephalitis | 1 | 2008 | 43 | 0.020 |
Why?
|
| Differential Threshold | 1 | 1988 | 27 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1988 | 52 | 0.020 |
Why?
|
| Autoanalysis | 1 | 1988 | 11 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1988 | 46 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1993 | 2077 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 187 | 0.020 |
Why?
|
| Tritium | 1 | 1987 | 101 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 57 | 0.020 |
Why?
|
| Darkness | 1 | 1987 | 27 | 0.020 |
Why?
|
| Proadifen | 1 | 1987 | 4 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 31 | 0.020 |
Why?
|
| Serotonin | 1 | 2007 | 144 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2006 | 20 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2006 | 134 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1987 | 532 | 0.020 |
Why?
|
| Thymus Gland | 2 | 1997 | 97 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 150 | 0.020 |
Why?
|
| Light | 1 | 1987 | 152 | 0.020 |
Why?
|
| Urea | 1 | 2006 | 51 | 0.020 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2006 | 24 | 0.020 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 1988 | 240 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2006 | 49 | 0.020 |
Why?
|
| Creatinine | 1 | 2006 | 243 | 0.020 |
Why?
|
| Spleen | 2 | 1997 | 301 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1199 | 0.020 |
Why?
|
| Indinavir | 1 | 2005 | 2 | 0.020 |
Why?
|
| Reflex | 1 | 2005 | 21 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2006 | 99 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 901 | 0.020 |
Why?
|
| Lamivudine | 1 | 2005 | 24 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 1 | 2005 | 25 | 0.020 |
Why?
|
| Memory | 1 | 2007 | 214 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 329 | 0.020 |
Why?
|
| Software | 1 | 1988 | 418 | 0.020 |
Why?
|
| Viral Load | 1 | 2005 | 127 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 1997 | 397 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2005 | 235 | 0.020 |
Why?
|
| Monocytes | 1 | 2005 | 210 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 208 | 0.020 |
Why?
|
| Kinetics | 1 | 1986 | 1047 | 0.020 |
Why?
|
| Piperazines | 1 | 2005 | 206 | 0.010 |
Why?
|
| Birth Weight | 2 | 1975 | 186 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2003 | 59 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 648 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 532 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 266 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2006 | 531 | 0.010 |
Why?
|
| Brain Stem | 1 | 2003 | 46 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 1329 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1293 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2003 | 156 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 945 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 1640 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 1999 | 18 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 1979 | 42 | 0.010 |
Why?
|
| Behavior | 1 | 1979 | 59 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 1998 | 5 | 0.010 |
Why?
|
| Densitometry | 1 | 1998 | 15 | 0.010 |
Why?
|
| Exploratory Behavior | 1 | 1999 | 79 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1998 | 92 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 54 | 0.010 |
Why?
|
| Lymphokines | 1 | 1997 | 49 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1997 | 93 | 0.010 |
Why?
|
| Deuterium | 1 | 1996 | 10 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1997 | 94 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1996 | 16 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1996 | 22 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1996 | 80 | 0.010 |
Why?
|
| Hydroxydopamines | 2 | 1989 | 25 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1997 | 329 | 0.010 |
Why?
|
| Calcium | 1 | 1979 | 929 | 0.010 |
Why?
|
| Grooming | 1 | 1974 | 5 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1976 | 215 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1996 | 737 | 0.010 |
Why?
|
| Fertility | 1 | 1974 | 60 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 1241 | 0.010 |
Why?
|
| RNA | 1 | 1975 | 171 | 0.010 |
Why?
|
| Cytokines | 1 | 1997 | 866 | 0.010 |
Why?
|
| DNA | 1 | 1975 | 597 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1971 | 8 | 0.010 |
Why?
|
| Visual Fields | 1 | 1971 | 41 | 0.010 |
Why?
|
| Proteins | 1 | 1975 | 473 | 0.010 |
Why?
|
| Cats | 1 | 1971 | 292 | 0.010 |
Why?
|
| Liver | 1 | 1976 | 1118 | 0.010 |
Why?
|
| Ergolines | 1 | 1989 | 19 | 0.010 |
Why?
|
| Oxidopamine | 1 | 1989 | 42 | 0.010 |
Why?
|
| Quinpirole | 1 | 1989 | 26 | 0.010 |
Why?
|
| Apomorphine | 1 | 1979 | 48 | 0.000 |
Why?
|
| Adenylyl Cyclases | 1 | 1979 | 94 | 0.000 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1979 | 36 | 0.000 |
Why?
|
| Dominance, Cerebral | 1 | 1979 | 65 | 0.000 |
Why?
|
| Seizures | 1 | 1979 | 279 | 0.000 |
Why?
|